The main programme for the 6th Annual NIF will feature more than 10 hours of high-level keynotes and panel discussions covering the latest developments in global biopartnering and investment, with additional panels covering scientific advances in key therapeutic areas of neurodegenerative diseases and CNS more broadly, which includes neuropsychiatry, ophthalmology, neurotech and digital therapeutics.
Click here to register!
Attend our presentation
Rare & Orphan & New Modalities
Time: 1:30pm PDT
Day: January 8, 2023
- Joel Sandler, PhD, Principal, BioConsulting, Cancer Cel Therapy Lead, Lumanity
- Sumant Kulkarni, Managing Director, Biotechnology Equity Research, Canaccord Genuity LLC
- Adam Bruce, Founder, Chairman & CEO, TikoMed AB
- Charles Stacey, President & CEO, Cerecin Inc
- Dave Miller, CSO, Unlearn.AI, Inc.
- Julien Veys, Chief Business Development Officer, Theranexus
- Luca Benatti, CEO, EryDel SpA